Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin)

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 222-225

  High, Kevin P ^a,b   Washburn, Ronald G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b BGSM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031024618     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.222     Document Type: Article

References (15)

1. Pannuti CS, Gingrich RD, Pfaller MA, Wenzel RP. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol 1991;9:77-84.
2. Bennett JE. Aspergillus species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:2306-11.
3. Thomson AW. FK506: profile of an important new immunosuppressant. Transplant Rev 1990;4:1-14.
4. Kahan BD, Chang JY, Sehgal SN. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation 1991;52:185-91.
5. Baker H, Sidorowicz A, Sehgal SN, Vezina C. Rapamycin (AY-22,989), a new antifungal antibiotic. J Antibiot 1978;31:539-45.
6. High KP, Handschumacher RE. Immunity, microbial pathogenesis, and immunophilins: finding the keys, now where are the locks? Infect Agents Dis 1992;1:121-35.
7. High KP. The antimicrobial activities of cyclosporin A, FK506 and rapamycin. Transplantation 1994;57:1689-700.
8. Torre-Cisneros J, Manex R, Kusne S, Allessiani M, Martin M, Starzl TE. The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc 1991; 23:3040-1.
9. Cosenza CA, Cramer DV, Makowka L. The use of immunosuppressive agents in animal models of experimental transplantation. In: Cramer DV, Posesta L, Makowka L, eds. Handbook of animal models in transplantation research. Boca Raton, FL: CRC Press, 1994:331-7.
10. Nagai H, Guo J, Choi II, Kurup V. Interferon-γ and tumor necrosis factor-α protect mice from invasive aspergillosis. J Infect Dis 1995;172:1554-60.
11. Brizuela L, Chrebet G, Bostian K, Parent SA. Antifungal properties of the immunosuppressant FK-506: identification of an FK-506-responsive yeast gene distinct from FKB1. Mol Cell Biol 1991;11:4616-26.
12. Cyert MS, Kunisawa R, Kaim D, Thorner J. Yeast has homologs (CNA1 and CNA2 gene products) of mammalian calcineurin, a calmodulin-regulated phosphoprotein phosphatase. Proc Natl Acad Sci USA 1991; 88:7376-80.
13. 1/S-phase growth arrest in T lymphocytes. J Biol Chem 1993;268:3734-8.
14. Koltin Y, Faucette L, Bergsma DJ, et al. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mol Cell Biol 1991;11:1718-23.
15. 1 progression. Cell 1993;73:585-96.